Taken together, the results of our study identify a novel positive feedback loop mechanism downstream of the canonical TGFβ/Smad signaling axis, mediated by a breast cancer anti-estrogen resistance gene, BCAR3. We report a novel role of BCAR3 to antagonize Smad signaling, efficiently leading to inhibition of the TGFβ’s biological functions in breast cancer cells. This evidence concerns the gene BCAR3 and breast carcinoma.